Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death

Long Chen1, Baoshan Xu, Lei Liu

  • 1Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA.

Insights

Cadmium exposure causes neurodegeneration by increasing reactive oxygen species (ROS), which activates the mTOR pathway. Antioxidants and inhibitors of PI3K/mTOR may prevent cadmium-induced neuronal cell death.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Cadmium (Cd) is a toxic environmental pollutant linked to neurodegenerative diseases.
  • Previous studies showed Cd activates the mammalian target of rapamycin (mTOR) pathway, contributing to neuronal apoptosis.
  • The precise mechanism by which Cd induces neurotoxicity remains unclear.

Purpose of the Study:

  • To elucidate the mechanism underlying cadmium-induced neurotoxicity.
  • To investigate the role of reactive oxygen species (ROS) and the mTOR pathway in Cd neurotoxicity.
  • To identify potential therapeutic targets for preventing Cd-induced neurodegeneration.

Main Methods:

  • Investigated Cd-induced ROS generation in PC12 and SH-SY5Y cells by measuring NADPH oxidase 2 and its regulatory proteins.
  • Utilized N-acetyl-l-cysteine (NAC) as a ROS scavenger to assess its impact on Cd-induced signaling.
  • Employed inhibitors of phosphoinositide 3-kinase (PI3K) and activators of AMP-activated protein kinase (AMPK), alongside genetic manipulation (PTEN overexpression).

Main Results:

  • Cd upregulates NADPH oxidase components, leading to increased ROS production in neuronal cells.
  • ROS generation is crucial for Cd-induced mTOR pathway activation, as NAC treatment prevents this.
  • Cd-induced ROS increases insulin-like growth factor receptor (IGFR) phosphorylation; PI3K inhibition and PTEN/AMPK activation attenuate Cd-induced apoptosis.

Conclusions:

  • Cd induces neuronal apoptosis via ROS generation, which activates the mTOR pathway.
  • This activation involves both stimulation of positive regulators (IGFR/PI3K) and inhibition of negative regulators (PTEN/AMPK).
  • Antioxidants, PI3K/mTOR inhibitors, and AMPK activators show potential for preventing Cd-induced neurodegeneration.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...